Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23940202 | 0.85 | LMNA (0.46) | HDAC1HDAC2LMNAALDH1A1BCHE | |
| SCHEMBL22810517 | 0.85 | LMNA (0.46) | HDAC1HDAC2LMNAALDH1A1HTT | |
| SCHEMBL23940250 | 0.82 | BRD4 (0.71) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL28968558 | 0.80 | HDAC1 (0.58) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL6586386 | 0.79 | NR4A2 (0.64) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL23940136 | 0.79 | CNR1 (0.46) | BRD4 | |
| SCHEMBL4104715 | 0.79 | ALDH1A1 (0.64) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL23940223 | 0.79 | HDAC1 (0.57) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL23940245 | 0.78 | ALDH1A1 (0.83) | HDAC1HDAC2LMNANR4A2ALDH1A1 | |
| SCHEMBL1093252 | 0.77 | BRD4 (0.69) | HDAC1HDAC2LMNANR4A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323966-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323966-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | TYK2, JAK3, JAK1 | HDAC1 714/4885HDAC2 327/4885LMNA 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.